Disclosures for "Understanding How Patients with Mild Cognitive Impairment and Alzheimer’s Disease Present at First Encounter: Toward a Standardized Framework for Therapy Eligibility"
-
Dr. Katramados has nothing to disclose.
-
Prof. Shin has nothing to disclose.
-
The institution of Dr. Vaughn has received research support from UCB. The institution of Dr. Vaughn has received research support from Evidera PPD. The institution of Dr. Vaughn has received research support from eMaxHealth. The institution of Dr. Vaughn has received research support from Lilly USA. The institution of Dr. Vaughn has received research support from Pfizer.
-
Dr. Poisson has received personal compensation in the range of $0-$499 for serving as a External Advisory Board member with Clinical Trials Methodology Course (NINDS).
-
Ms. Tundo has nothing to disclose.
-
Dr. Novikova has a non-compensated relationship as a Uncomprensated Board Member with Alzheimer's Association - Michigan chapter that is relevant to AAN interests or activities.
-
Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma.